Red blood cells vs Bacillus anthracis, now in technicolor! More from Microbiology & Immunology – “A newly developed drug, modeled after a bacteriophage, is less likely to encounter antibiotic resistance. The drug mimics cell-wall busting viral enzymes called lysins. Viral lysins appear to resist bacterial evolution that would render them ineffective over time. The new drug, dubbed Epimerox, was tested against Bacillus anthracis.”
Read more here.